ORIGINAL ARTICLE
Year : 2014  |  Volume : 7  |  Issue : 3  |  Page : 317-320

Association of serum Interlukin-6 and glycolysis in sickle cell disease patients


Department of Biochemistry, MGM Medical College, Indore, Madhya Pradesh, India

Correspondence Address:
Gopinath Agnihotram
MGM Medical College, Indore - 452 001, Madhya Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0975-2870.128973

Rights and Permissions

Background: Glycolysis, a major cytosolic oxidative pathway of glucose, is intended for the supply of energy in RBC and, moreover, for the production of 2,3 Bisphsophoglycerate through the Rapaport-Lubering shunt, which delivers oxygen more readily to the tissues. Interleukin 6 (IL-6) is a pro-inflammatory cytokine, playing a pivotal role in the inflammation process and mediating the acute phase process. Aim: This study aimed to investigate the association of the inflammatory parameter, serum IL-6, and glycolytic metabolism in the erythrocytes of sickle cell disease patients. Materials and Methods: This cross-sectional study was performed using a cohort of patients (90 sickle cell disease patients and 60 healthy age-matched controls) followed at the General Medicine Department of MGM Medical College, Indore. Glucose uptake, Hexokinase-2, pyruvate, lactate and 2,3 Bisphosphoglycerate levels were estimated in the RBC by relevant chemical kit methods on an autoanalyzer and enzyme-linked immunosorbent assay (ELISA), respectively. Serum IL-6 is estimated through the ELISA kit method. Statistical analysis was performed by using the Student's unpaired "t" test and Pearson's correlation test. P < 0.05 was considered statistically significant. Results: All glycolytic parameters were elevated along with IL-6 in sickle cell disease when compared with controls. A positive correlation was observed between the IL-6 level and glucose uptake (r = 0.345, P < 0.001), pyruvate (r = 0.512, P < 0.001) and lactate of RBC. Conclusion: This study shows that increased levels of plasma IL-6 might enhance the rate of glycolysis in RBC through the STAT3 pathway in sickle cell disease patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2123    
    Printed35    
    Emailed0    
    PDF Downloaded206    
    Comments [Add]    

Recommend this journal